Gladstone scientists reprogram skin cells into insulin-producing pancreas cells
A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it. But now scientists in the laboratory of Gladstone Institutes’ Investigator Sheng Ding, MD, PhD, harnessing the power of regenerative medicine, have developed a technique in animal models that could replenish the very cells destroyed by the disease. The team’s findings, published online today in the journal Cell Stem Cell, are an important step towards freeing patients from the life-long injections that characterize this devastating disease.
Type 1 diabetes, which usually manifests during childhood, is caused by the destruction of beta-cells (?-cells). ?-cells are a type of cell that normally resides in the pancreas and produces a hormone called insulin. Without insulin, the body’s organs have difficulty absorbing sugars, such as glucose, from the blood. Once a death sentence, the disease can now be managed with regular glucose monitoring and insulin injections. A more permanent solution, however, would be to replace the missing ?-cells. But these cells are hard to come by, so researchers have looked towards stem cell technology as a way to make them.
“The power of regenerative medicine is that it can potentially provide an unlimited source of functional, insulin-producing ?-cells that can then be transplanted into the patient,” said Dr. Ding. “But previous attempts to produce large quantities of healthy ?-cells—and to develop a workable delivery system—have not been entirely successful. So we took a somewhat different approach.”
One of the major challenges to generating large quantities of ?-cells is that these cells have limited regenerative ability; once they mature it’s difficult to make more. So the team decided to go one step backwards in the life cycle of the cell.
The team first collected skin cells, called fibroblasts, from laboratory mice. Then, by treating the fibroblasts with a unique ‘cocktail’ of molecules and reprogramming factors, they transformed the cells into endoderm-like cells. Endoderm cells are a type of cell found in the early embryo, and which eventually mature into the body’s major organs—including the pancreas, the home of ?-cells.
“Using another chemical cocktail, we then transformed these endoderm-like cells into cells that mimicked early pancreas-like cells, which we called PPLC’s,” said Gladstone Postdoctoral Scholar Ke Li, PhD, the paper’s lead author. “Our initial goal was to see whether we could coax these PPLC’s to mature into cells that, like ?-cells, respond to the correct chemical signals and—most importantly—secrete insulin. And our initial experiments, performed in a petri dish, revealed that they did.”
The research team then wanted to see whether the same would occur in live animal models. So they transplanted PPLC’s into mice modified to have hyperglycemia (high glucose levels), a key indicator of diabetes.
“Importantly, just one week post-transplant, the animals’ glucose levels started to decrease, and gradually approached normal levels,” continued Dr. Li. “And when we removed the transplanted cells, we saw an immediate glucose spike, revealing a direct link between the transplantation of the PPLC’s and reduced hyperglycemia.”
But it was when the team tested the mice eight weeks post-transplant that they saw more dramatic changes: the PPLC’s had given rise to functional, insulin-secreting ?-cells.
“These results not only highlight the power of small molecules in cellular reprogramming, and are proof-of-principle that could one day be used as a personalized therapeutic approach in patients,” explained Dr. Ding.
The Latest on: Type 1 Diabetes
[google_news title=”” keyword=”Type 1 Diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Type 1 Diabetes
- Scientists develop experimental type 1 diabetes drug which shields insulin-making cells from immune system attackon May 7, 2024 at 2:55 pm
Research into an experimental type 1 diabetes drug has shown that it appears to stop and reverse the condition in mice, and can even prolong their life. The antibody drug, called mAb43, works by ...
- Experimental Type 1 Diabetes Drug Shelters Pancreas Cells from Immune System Attackon May 7, 2024 at 11:12 am
Scientists say an experimental antibody drug appears to prevent and reverse type 1 diabetes in mice—and often lengthen their lives.
- 'Mother of all Galas' for Type 1 Diabetes researchon May 7, 2024 at 10:54 am
A Belton couple was arrested after deputies said they moved into a home that was being sold - without legally buying it. The Asheville Police Department said a man has been arrested after using an ...
- Know the symptoms of type 1 diabetes to help your child lead a normal lifeon May 6, 2024 at 4:59 pm
But if your child is suddenly drowsier than usual, is frequently thirsty, gets tired easily and loses weight drastically, it could be a symptom of type 1 diabetes. Type 1 diabetes is an autoimmune ...
- Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical careon May 6, 2024 at 3:50 pm
Population-wide screening of children for presymptomatic early-stage type 1 diabetes is gaining momentum. Studies have demonstrated feasibility and acceptance, and shown that the rate of progression ...
- Kentucky Derby event supports kids with Type 1 Diabeteson May 4, 2024 at 5:01 am
A Kentucky Derby event supporting kids with type 1 diabetes is also taking place today. The event shines a light on kids who are strong and resilient in life while managing this disease.
- 'Woozy, but OK': Hiker with type 1 diabetes completes West Coast Trail in 32 hourson May 4, 2024 at 5:00 am
Chris Jarvis was pushing his limits to mark the 30th year since his diagnosis and to raise funds and the profile of his charity, I Challenge Diabetes ...
- New study reveals diet beneficial for type 1 diabeteson May 4, 2024 at 1:48 am
Researchers have found a diet that could have beneficial effects for people with type 1 diabetes.
- Heritability of Type 1 Diabetes Higher for Pediatric- vs Adult-Onset Diseaseon May 1, 2024 at 5:39 am
Researchers conducted a register-based cohort study to compare the heritability of type 1 diabetes among individuals with pediatric- and adult-onset type 1 diabetes.
- Experimental monoclonal antibody prevents and reverses clinical type 1 diabetes in miceon April 30, 2024 at 11:47 am
Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to ...
via Bing News